Correlation Between Cue Biopharma and Apogee Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Cue Biopharma and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Apogee Therapeutics,.
Diversification Opportunities for Cue Biopharma and Apogee Therapeutics,
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cue and Apogee is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Apogee Therapeutics, go up and down completely randomly.
Pair Corralation between Cue Biopharma and Apogee Therapeutics,
Considering the 90-day investment horizon Cue Biopharma is expected to generate 1.19 times more return on investment than Apogee Therapeutics,. However, Cue Biopharma is 1.19 times more volatile than Apogee Therapeutics, Common. It trades about 0.0 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.23 per unit of risk. If you would invest 134.00 in Cue Biopharma on November 29, 2024 and sell it today you would lose (3.00) from holding Cue Biopharma or give up 2.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cue Biopharma vs. Apogee Therapeutics, Common
Performance |
| Timeline |
| Cue Biopharma |
| Apogee Therapeutics, |
Cue Biopharma and Apogee Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Apogee Therapeutics,
The main advantage of trading using opposite Cue Biopharma and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Anixa Biosciences |
| Apogee Therapeutics, vs. NuRAN Wireless | Apogee Therapeutics, vs. Gentex | Apogee Therapeutics, vs. BCE Inc | Apogee Therapeutics, vs. Space Communication |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |